Markets:

Overview

News

Currencies

International

Treasuries

Haemonetics Corporation Common Stock (NY:HAE)

65.49 +3.55 (+5.73%)

Official Closing Price Updated: 7:00 PM EDT, May 22, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Haemonetics Corporation Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

1 Russell 2000 Stock to Research Further and 2 Facing Headwinds

August 22, 2025

The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the...

Via StockStory

3 Cash-Producing Stocks with Open Questions

August 18, 2025

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak...

Via StockStory

HAE Q2 Deep Dive: Margin Expansion Amid Revenue Decline and Product Execution Challenges

August 11, 2025

Blood products company Haemonetics (NYSE:HAE). beat Wall Street’s revenue expectations in Q2 CY2025, but sales fell by 4.4% year on year to $321.4 million. Its non-GAAP profit of $1.10 per share was...

Via StockStory

These Analysts Slash Their Forecasts On Haemonetics After Q1 Results ↗

August 08, 2025

Via Benzinga

Earnings Scheduled For August 7, 2025 ↗

August 07, 2025

Via Benzinga

Earnings Scheduled For May 8, 2025 ↗

May 08, 2025

Via Benzinga

How Do Investors Really Feel About Haemonetics? ↗

April 23, 2025

Via Benzinga

This Trade Desk Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday ↗

August 08, 2025

Via Benzinga

A Glimpse Into The Expert Outlook On Haemonetics Through 6 Analysts ↗

August 08, 2025

Via Benzinga

Haemonetics (NYSE:HAE) Surprises With Strong Q2 But Stock Drops 24%

August 07, 2025

Blood products company Haemonetics (NYSE:HAE). reported Q2 CY2025 results topping the market’s revenue expectations, but sales fell by 4.4% year on year to $321.4 million. Its non-GAAP profit of $1.10...

Via StockStory

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

August 07, 2025

Via Benzinga

Haemonetics (HAE) Q1 Revenue Falls 4% ↗

August 07, 2025

Via The Motley Fool

Peering Into Haemonetics's Recent Short Interest ↗

August 06, 2025

Via Benzinga

Haemonetics (HAE) To Report Earnings Tomorrow: Here Is What To Expect

August 05, 2025

Blood products company Haemonetics (NYSE:HAE). will be reporting results this Thursday morning. Here’s what you need to know.

Via StockStory

Topics World Trade

Peering Into Haemonetics's Recent Short Interest ↗

July 22, 2025

Via Benzinga

Lantheus, ICU Medical, Haemonetics, CONMED, and Astrana Health Shares Plummet, What You Need To Know

July 11, 2025

A number of stocks fell in the afternoon session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada.

Via StockStory

Topics ETFs Stocks World Trade

Unpacking Q1 Earnings: Haemonetics (NYSE:HAE) In The Context Of Other Medical Devices & Supplies - Specialty Stocks

July 09, 2025

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Haemonetics (NYSE:HAE) and the best and...

Via StockStory

1 Healthcare Stock to Target This Week and 2 to Be Wary Of

July 03, 2025

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory...

Via StockStory

Topics Stocks

3 Profitable Stocks Facing Headwinds

June 27, 2025

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

Via StockStory

Analyst Expectations For Haemonetics's Future ↗

June 26, 2025

Via Benzinga

3 Russell 2000 Stocks Skating on Thin Ice

June 09, 2025

The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher...

Via StockStory

Topics Economy

HAE Q1 Earnings Call: Revenue Misses Expectations, Margin Expansion and Product Focus Highlighted

June 05, 2025

Blood products company Haemonetics (NYSE:HAE). fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 3.7% year on year to $330.6 million. Its non-GAAP EPS of $1.24 per share...

Via StockStory

1 Value Stock to Target This Week and 2 to Question

June 04, 2025

Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are...

Via StockStory

What 4 Analyst Ratings Have To Say About Haemonetics ↗

May 20, 2025

Via Benzinga

1 Healthcare Stock to Consider Right Now and 2 to Brush Off

May 09, 2025

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Despite the rosy long-term prospects, short-term headwinds such as COVID...

Via StockStory

Topics Stocks

Haemonetics (NYSE:HAE) Surprises With Q1 Sales

May 08, 2025

Blood products company Haemonetics (NYSE:HAE). beat Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 3.7% year on year to $330.6 million. Its non-GAAP profit of $1.24 per share was...

Via StockStory

Haemonetics (HAE) To Report Earnings Tomorrow: Here Is What To Expect

May 07, 2025

Blood products company Haemonetics (NYSE:HAE). will be reporting results tomorrow before market open. Here’s what you need to know.

Via StockStory

Topics Artificial Intelligence

1 Profitable Stock Worth Your Attention and 2 to Question

April 27, 2025

A company with profits isn’t always a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.

Via StockStory

HAEMONETICS CORP/MASS (NYSE:HAE) is an undervalued gem with solid fundamentals. ↗

April 17, 2025

HAEMONETICS CORP/MASS has caught the attention as a great value stock. NYSE:HAE excels in profitability, solvency, and liquidity, all while being very reasonably priced.

Via Chartmill

Spotting Winners: STAAR Surgical (NASDAQ:STAA) And Medical Devices & Supplies - Specialty Stocks In Q4

April 11, 2025

Looking back on medical devices & supplies - specialty stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including STAAR Surgical (NASDAQ:STAA) and its peers.

Via StockStory

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.